HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterogeneous interleukin-15 inducibilities in murine B16 melanoma and RM-1 prostate carcinoma by interferon-alpha treatment.

Abstract
Long-term treatment of mouse cancer cells with interferon-alpha (IFN-alpha) converts parental B16 melanoma cells to B16alpha vaccine cells. Inoculation of syngeneic mice with UV-irradiated B16alpha vaccine cells triggers immunity to the parental B16 tumor that is mediated by host macrophages, T cells, and NK cells. Lymph node cells from mice inoculated with irradiated B16alpha vaccine cells, but not with irradiated parental cells, proliferate when cultured in vitro, suggesting long-term in vivo activation of lymphoid cells. Both IL-15 mRNA and IL-15 protein are highly induced in B16alpha vaccine cells. The bulk of the induced IL-15 is shown to be cell-associated, either cytoplasmic or membranous. The current study investigated the feasibility of applying the B16alpha vaccination protocol to generate a cancer vaccine against murine RM-1 prostate carcinoma. In comparison to B16alpha vaccine cells, long-term IFN-alpha-treated RM-1 cells (RM-1alpha vaccine cells) showed significant IL-15 mRNA induction but relatively low IL-15 protein up-regulation. When UV-irradiated, a 3-fold increase in intracellular IL-15 was observed in RM-1alpha vaccine cells, suggesting UV damage may have negated a possible control mechanism for IL-15 synthesis. Efficacy of in vivo vaccination of syngeneic mice with UV-irradiated RM-1alpha and B16alpha vaccine cells showed correlation between high IL-15 level and high vaccine efficacy in B16alpha cells compared to low IL-15 level and low vaccine efficacy in RM-1alpha cells. This supports the concept that the induction of IL-15 in tumor cells can be useful for creating whole-cell cancer vaccines.
AuthorsTzu G Wu, Joana R Perdigão, Theresa K Umhoefer, Jade Cao, David A Ansari, Thomas B Albrecht, Eugene P Knutson, William A Rose 2nd, Angela J Jorgensen, Lee M Ryan, Linda E Abdalla, William Robert Fleischmann Jr
JournalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (J Interferon Cytokine Res) Vol. 29 Issue 11 Pg. 719-28 (Nov 2009) ISSN: 1557-7465 [Electronic] United States
PMID19642895 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cancer Vaccines
  • Interferon-alpha
  • Interleukin-15
  • RNA, Messenger
Topics
  • Animals
  • Cancer Vaccines
  • Carcinoma (immunology, pathology, prevention & control)
  • Interferon-alpha (immunology, metabolism)
  • Interleukin-15 (biosynthesis, genetics, immunology)
  • Lymphocyte Activation
  • Male
  • Melanoma, Experimental (genetics, immunology, pathology, prevention & control)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Prostatic Neoplasms (genetics, immunology, pathology, prevention & control)
  • Protein Biosynthesis (immunology)
  • RNA, Messenger (analysis)
  • Transcriptional Activation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: